Wu V, Kiriazov B, Koch K, Gu V, Beck A, Borcherding N
Mol Cancer Res. 2019; 18(1):46-56.
PMID: 31619506
PMC: 6942205.
DOI: 10.1158/1541-7786.MCR-19-0359.
Linnenbringer E, Gehlert S, Geronimus A
AIMS Public Health. 2018; 4(5):526-556.
PMID: 29333472
PMC: 5764177.
DOI: 10.3934/publichealth.2017.5.526.
Cardoso F, Costa A, Senkus E, Aapro M, Andre F, Barrios C
Ann Oncol. 2017; 28(1):16-33.
PMID: 28177437
PMC: 5378224.
DOI: 10.1093/annonc/mdw544.
Zhang W, Chang Z, Shi K, Song L, Cui L, Ma Z
Oncol Lett. 2016; 11(3):1995-2000.
PMID: 26998112
PMC: 4774582.
DOI: 10.3892/ol.2016.4193.
Kochan D, Kovalchuk O
Oncotarget. 2015; 6(19):16866-82.
PMID: 26220712
PMC: 4627279.
DOI: 10.18632/oncotarget.4343.
Mechanisms of resistance to endocrine therapy in breast cancer: focus on signaling pathways, miRNAs and genetically based resistance.
Garcia-Becerra R, Santos N, Diaz L, Camacho J
Int J Mol Sci. 2013; 14(1):108-45.
PMID: 23344024
PMC: 3565254.
DOI: 10.3390/ijms14010108.
The mitochondrial citrate transporter, CIC, is essential for mitochondrial homeostasis.
Catalina-Rodriguez O, Kolukula V, Tomita Y, Preet A, Palmieri F, Wellstein A
Oncotarget. 2012; 3(10):1220-35.
PMID: 23100451
PMC: 3717962.
DOI: 10.18632/oncotarget.714.
Epigenetic mechanisms in commonly occurring cancers.
Blair L, Yan Q
DNA Cell Biol. 2012; 31 Suppl 1:S49-61.
PMID: 22519822
PMC: 3460614.
DOI: 10.1089/dna.2012.1654.
Functional activation of the estrogen receptor-α and aromatase by the HDAC inhibitor entinostat sensitizes ER-negative tumors to letrozole.
Sabnis G, Goloubeva O, Chumsri S, Nguyen N, Sukumar S, Brodie A
Cancer Res. 2011; 71(5):1893-903.
PMID: 21245100
PMC: 3076193.
DOI: 10.1158/0008-5472.CAN-10-2458.
Identification of primary gene targets of TFAP2C in hormone responsive breast carcinoma cells.
Woodfield G, Chen Y, Bair T, Domann F, Weigel R
Genes Chromosomes Cancer. 2010; 49(10):948-62.
PMID: 20629094
PMC: 2928401.
DOI: 10.1002/gcc.20807.
The epigenetics of breast cancer.
Jovanovic J, Ronneberg J, Tost J, Kristensen V
Mol Oncol. 2010; 4(3):242-54.
PMID: 20627830
PMC: 5527941.
DOI: 10.1016/j.molonc.2010.04.002.
Epigenetic targeting in breast cancer: therapeutic impact and future direction.
Lustberg M, Ramaswamy B
Drug News Perspect. 2009; 22(7):369-81.
PMID: 19890494
PMC: 3658161.
DOI: 10.1358/dnp.2009.22.7.1405072.
Interaction of TFAP2C with the estrogen receptor-alpha promoter is controlled by chromatin structure.
Woodfield G, Hitchler M, Chen Y, Domann F, Weigel R
Clin Cancer Res. 2009; 15(11):3672-9.
PMID: 19458056
PMC: 2776721.
DOI: 10.1158/1078-0432.CCR-08-2343.
Progesterone receptor B recruits a repressor complex to a half-PRE site of the estrogen receptor alpha gene promoter.
De Amicis F, Zupo S, Panno M, Malivindi R, Giordano F, Barone I
Mol Endocrinol. 2009; 23(4):454-65.
PMID: 19147702
PMC: 2725766.
DOI: 10.1210/me.2008-0267.
Neuroendocrine consequences of androgen excess in female rodents.
Foecking E, McDevitt M, Acosta-Martinez M, Horton T, Levine J
Horm Behav. 2008; 53(5):673-92.
PMID: 18374922
PMC: 2413177.
DOI: 10.1016/j.yhbeh.2007.12.013.
17beta-Oestradiol treatment modulates nitric oxide synthase activity in MDA231 tumour with implications on growth and radiation response.
Chinje E, Williams K, Telfer B, Wood P, van der Kogel A, Stratford I
Br J Cancer. 2002; 86(1):136-42.
PMID: 11857025
PMC: 2746548.
DOI: 10.1038/sj.bjc.6600032.
A novel endocrine-disrupting agent in corn with mitogenic activity in human breast and prostatic cancer cells.
Markaverich B, Mani S, Alejandro M, Mitchell A, Markaverich D, Brown T
Environ Health Perspect. 2002; 110(2):169-77.
PMID: 11836146
PMC: 1240732.
DOI: 10.1289/ehp.02110169.
Role of DNA methylation and histone acetylation in steroid receptor expression in breast cancer.
Yan L, Yang X, Davidson N
J Mammary Gland Biol Neoplasia. 2001; 6(2):183-92.
PMID: 11501578
DOI: 10.1023/a:1011308707512.
The loss of estrogen and progesterone receptor gene expression in human breast cancer.
Lapidus R, Nass S, Davidson N
J Mammary Gland Biol Neoplasia. 2000; 3(1):85-94.
PMID: 10819507
DOI: 10.1023/a:1018778403001.
Estrogen receptor variants.
Hopp T, Fuqua S
J Mammary Gland Biol Neoplasia. 2000; 3(1):73-83.
PMID: 10819506
DOI: 10.1023/a:1018726418931.